Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-04-23FDA Approved: SPIRONOLACTONE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original ANDA for spironolactone, authorizing a generic version manufactured by Jubilant Cadista Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2014-04-23Clinical Trial Update: Effect of Managing Problematic Eating Behaviours With Dietary Management on Chronic Disease Self-management [NA]
A completed clinical trial evaluating whether dietary management of problematic eating behaviors improves chronic disease self-management in…
-
FDA approval · 2014-04-21FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the combination product amlodipine besylate and atorvastatin calcium from Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine [Phase 1]
Phase I study evaluating the effect on blood pressure after oral administration of SK3530 with amlodipine in hypertension; the study has com…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Effect of Mat Pilates Training on Blood Pressure of Hypertensive Individuals [NA]
A completed trial evaluated the impact of Mat Pilates training on blood pressure in individuals with hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-04-18FDA Approved: EDARBYCLOR — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for EDARBYCLOR (azilsartan medoxomil and chlorthalidone) submitted by Azurity Pharmaceuticals, l…
-
FDA approval · 2014-04-18FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EDARBI (azilsartan medoxomil) submitted by Azurity Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) [Phase 1]
Phase 1 study evaluating potential drug–drug interactions between Telmisartan/S-Amlodipine and Rosuvastatin completed.
-
CLINICAL_TRIALS research · 2014-04-17Clinical Trial Update: Novel Approaches in Linkage Analysis for Complex Traits
This Mayo Clinic-sponsored clinical trial update describes novel linkage-analysis approaches for complex traits in cardiovascular conditions…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic [Phase 3]
A Phase 3 clinical trial evaluating strategies to sustain control of cardiac risk factors after discharge from a cardiovascular risk reducti…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction [NA]
Clinical trial update describing renal denervation in patients with heart failure with preserved ejection fraction and hypertension; the tri…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Physical Fitness, Cardiovascular and Brain Health [NA]
This document notes that a University of Texas at Austin trial examining physical fitness, cardiovascular function, and brain health in indi…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating a multi-targeted cardiac risk intervention in type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: Effect of an Apple Polyphenol Extract on Brachial Artery Flow-mediated Vasodilatory Function [Phase 2]
Phase 2 clinical trial evaluating the effect of an apple polyphenol extract on brachial artery flow-mediated dilation in individuals with bo…
-
CLINICAL_TRIALS withdrawal · 2014-04-04Clinical Trial Update: Where Should Automated Blood Pressures be Done in Primary Care Offices?
A clinical trial evaluating where automated blood pressure measurements should be taken in primary care offices has been withdrawn.
-
FDA approval · 2014-04-03FDA Approved: NIFEDIPINE — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories' original ANDA for a generic nifedipine product.
-
EMA withdrawal · 2014-04-02EMA Withdrawn: Onduarp (telmisartan) — Boehringer Ingelheim International GmbH
The EMA withdrew Onduarp (telmisartan) from Boehringer Ingelheim International GmbH, with the decision in 2014, in the hypertension therapeu…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study [NA]
This document reports on a completed Stanford University study evaluating pine bark extract as a treatment for hypertension, with results po…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem [Phase 1, Phase 2]
A completed Phase 1/2 trial comparing labetalol and diltiazem to control emergence blood pressure during craniotomy for brain tumor surgery.
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Impact of Oranges on Cardiovascular Health [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating whether orange consumption affects blood pressure, endothelial function, and overall c…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Hypertension in Black Americans: A Life Course Approach
The clinical trial examining hypertension across the life course in Black Americans (sponsored by Duke University) has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Team Management of High Blood Pressure [NA]
A completed clinical trial evaluating team-based management strategies for hypertension.
-
FDA approval · 2014-03-26FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves a supplemental application for Losartan Potassium submitted by Lupin Pharmaceuticals, Inc., under an ANDA.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Continued Safety and Performance of the TIVUS System [Phase 2, Phase 3]
This update reports ongoing safety and performance data for the TIVUS System in Phase 2 and Phase 3 trials for hypertension, including resis…
-
CLINICAL_TRIALS research · 2014-03-26Clinical Trial Update: Associations of Exposure to Bisphenol A With Blood Pressure and Epigenetic Change [NA]
A completed clinical trial investigating associations between Bisphenol A exposure and blood pressure changes and related epigenetic changes…